Could ditching Beta-Blockers boost energy in heart disease patients?
NCT ID NCT05019027
First seen Nov 01, 2025 · Last updated Apr 24, 2026 · Updated 17 times
Summary
This study looks at whether older adults (65+) with a specific type of heart disease called TTR cardiac amyloidosis feel better when they stop taking a common heart medication called a beta-blocker. Twenty participants will go through two periods—one on the drug and one off—to compare their exercise ability and quality of life. The goal is to see if stopping the medication can improve daily living without causing harm.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEART DISEASES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Weill Cornell Medicine
New York, New York, 10065, United States
Conditions
Explore the condition pages connected to this study.